Logo image of MCHPP

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) Stock Fundamental Analysis

USA - NASDAQ:MCHPP - US5950173022

61.32 USD
+0.7 (+1.15%)
Last: 10/3/2025, 2:06:40 PM
Fundamental Rating

4

Taking everything into account, MCHPP scores 4 out of 10 in our fundamental rating. MCHPP was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. MCHPP has an average financial health and profitability rating. MCHPP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MCHPP had positive earnings in the past year.
MCHPP had a positive operating cash flow in the past year.
MCHPP had positive earnings in 4 of the past 5 years.
MCHPP had a positive operating cash flow in each of the past 5 years.
MCHPP Yearly Net Income VS EBIT VS OCF VS FCFMCHPP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.21%, MCHPP is in line with its industry, outperforming 44.64% of the companies in the same industry.
With a Return On Equity value of -2.63%, MCHPP perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.19%, MCHPP is in line with its industry, outperforming 50.00% of the companies in the same industry.
MCHPP had an Average Return On Invested Capital over the past 3 years of 11.93%. This is in line with the industry average of 10.93%.
The last Return On Invested Capital (1.19%) for MCHPP is well below the 3 year average (11.93%), which needs to be investigated, but indicates that MCHPP had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.21%
ROE -2.63%
ROIC 1.19%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
MCHPP Yearly ROA, ROE, ROICMCHPP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

MCHPP has a Operating Margin of 4.91%. This is comparable to the rest of the industry: MCHPP outperforms 53.57% of its industry peers.
MCHPP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 54.48%, MCHPP is in the better half of the industry, outperforming 72.32% of the companies in the same industry.
In the last couple of years the Gross Margin of MCHPP has declined.
Industry RankSector Rank
OM 4.91%
PM (TTM) N/A
GM 54.48%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
MCHPP Yearly Profit, Operating, Gross MarginsMCHPP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MCHPP is still creating some value.
MCHPP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MCHPP has more shares outstanding
MCHPP has a better debt/assets ratio than last year.
MCHPP Yearly Shares OutstandingMCHPP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
MCHPP Yearly Total Debt VS Total AssetsMCHPP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

An Altman-Z score of 3.38 indicates that MCHPP is not in any danger for bankruptcy at the moment.
MCHPP has a Altman-Z score (3.38) which is in line with its industry peers.
The Debt to FCF ratio of MCHPP is 7.52, which is on the high side as it means it would take MCHPP, 7.52 years of fcf income to pay off all of its debts.
MCHPP's Debt to FCF ratio of 7.52 is in line compared to the rest of the industry. MCHPP outperforms 51.79% of its industry peers.
MCHPP has a Debt/Equity ratio of 0.80. This is a neutral value indicating MCHPP is somewhat dependend on debt financing.
MCHPP has a Debt to Equity ratio of 0.80. This is amonst the worse of the industry: MCHPP underperforms 80.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.52
Altman-Z 3.38
ROIC/WACC0.11
WACC11.01%
MCHPP Yearly LT Debt VS Equity VS FCFMCHPP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.31 indicates that MCHPP has no problem at all paying its short term obligations.
MCHPP has a worse Current ratio (2.31) than 67.86% of its industry peers.
MCHPP has a Quick Ratio of 1.33. This is a normal value and indicates that MCHPP is financially healthy and should not expect problems in meeting its short term obligations.
MCHPP's Quick ratio of 1.33 is on the low side compared to the rest of the industry. MCHPP is outperformed by 80.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.33
MCHPP Yearly Current Assets VS Current LiabilitesMCHPP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. Growth

3.1 Past

MCHPP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.63%.
Measured over the past years, MCHPP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.29% on average per year.
MCHPP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.70%.
MCHPP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.55% yearly.
EPS 1Y (TTM)-72.63%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-49.06%
Revenue 1Y (TTM)-35.7%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-13.36%

3.2 Future

The Earnings Per Share is expected to grow by 29.71% on average over the next years. This is a very strong growth
MCHPP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.04% yearly.
EPS Next Y16.62%
EPS Next 2Y43.36%
EPS Next 3Y40.36%
EPS Next 5Y29.71%
Revenue Next Year5.46%
Revenue Next 2Y12.91%
Revenue Next 3Y14.64%
Revenue Next 5Y10.04%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCHPP Yearly Revenue VS EstimatesMCHPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
MCHPP Yearly EPS VS EstimatesMCHPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

MCHPP is valuated quite expensively with a Price/Earnings ratio of 58.96.
MCHPP's Price/Earnings ratio is in line with the industry average.
MCHPP is valuated expensively when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 22.95, which indicates a rather expensive current valuation of MCHPP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MCHPP indicates a somewhat cheap valuation: MCHPP is cheaper than 75.89% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MCHPP to the average of the S&P500 Index (23.29), we can say MCHPP is valued inline with the index average.
Industry RankSector Rank
PE 58.96
Fwd PE 22.95
MCHPP Price Earnings VS Forward Price EarningsMCHPP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MCHPP's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, MCHPP is valued a bit cheaper than 70.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 45.61
EV/EBITDA 39.98
MCHPP Per share dataMCHPP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MCHPP does not grow enough to justify the current Price/Earnings ratio.
MCHPP's earnings are expected to grow with 40.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.55
PEG (5Y)N/A
EPS Next 2Y43.36%
EPS Next 3Y40.36%

4

5. Dividend

5.1 Amount

MCHPP has a Yearly Dividend Yield of 2.76%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.20, MCHPP pays a better dividend. On top of this MCHPP pays more dividend than 91.96% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, MCHPP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.76%

5.2 History

On average, the dividend of MCHPP grows each year by 20.15%, which is quite nice.
MCHPP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)20.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of MCHPP are negative and hence is the payout ratio. MCHPP will probably not be able to sustain this dividend level.
The dividend of MCHPP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-555.76%
EPS Next 2Y43.36%
EPS Next 3Y40.36%
MCHPP Yearly Income VS Free CF VS DividendMCHPP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28

NASDAQ:MCHPP (10/3/2025, 2:06:40 PM)

61.32

+0.7 (+1.15%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners104.37%
Inst Owner ChangeN/A
Ins Owners1.93%
Ins Owner ChangeN/A
Market Cap33.09B
Analysts80
Price Target72.81 (18.74%)
Short Float %0.08%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield 2.76%
Yearly Dividend1.81
Dividend Growth(5Y)20.15%
DP-555.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)2.6%
Max EPS beat(2)11.8%
EPS beat(4)3
Avg EPS beat(4)-2.11%
Min EPS beat(4)-27.71%
Max EPS beat(4)11.8%
EPS beat(8)4
Avg EPS beat(8)-1.35%
EPS beat(12)4
Avg EPS beat(12)-1.31%
EPS beat(16)6
Avg EPS beat(16)-0.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)-0.05%
Revenue beat(8)0
Avg Revenue beat(8)-2%
Revenue beat(12)0
Avg Revenue beat(12)-1.83%
Revenue beat(16)0
Avg Revenue beat(16)-1.7%
PT rev (1m)0.59%
PT rev (3m)15.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.82%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)8.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.16%
Valuation
Industry RankSector Rank
PE 58.96
Fwd PE 22.95
P/S 7.81
P/FCF 45.61
P/OCF 41.54
P/B 4.83
P/tB N/A
EV/EBITDA 39.98
EPS(TTM)1.04
EY1.7%
EPS(NY)2.67
Fwd EY4.36%
FCF(TTM)1.34
FCFY2.19%
OCF(TTM)1.48
OCFY2.41%
SpS7.85
BVpS12.71
TBVpS-3.95
PEG (NY)3.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.21%
ROE -2.63%
ROCE 1.51%
ROIC 1.19%
ROICexc 1.24%
ROICexgc 3.88%
OM 4.91%
PM (TTM) N/A
GM 54.48%
FCFM 17.13%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
ROICexc(3y)12.2%
ROICexc(5y)10.52%
ROICexgc(3y)48.65%
ROICexgc(5y)43.88%
ROCE(3y)15.1%
ROCE(5y)13.02%
ROICexcg growth 3Y-44.39%
ROICexcg growth 5Y-17.88%
ROICexc growth 3Y-40.07%
ROICexc growth 5Y-9.14%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.52
Debt/EBITDA 5.8
Cap/Depr 9.69%
Cap/Sales 1.68%
Interest Coverage 250
Cash Conversion 84.69%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.33
Altman-Z 3.38
F-Score4
WACC11.01%
ROIC/WACC0.11
Cap/Depr(3y)32.64%
Cap/Depr(5y)27.66%
Cap/Sales(3y)4.12%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.63%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-49.06%
EPS Next Y16.62%
EPS Next 2Y43.36%
EPS Next 3Y40.36%
EPS Next 5Y29.71%
Revenue 1Y (TTM)-35.7%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-13.36%
Revenue Next Year5.46%
Revenue Next 2Y12.91%
Revenue Next 3Y14.64%
Revenue Next 5Y10.04%
EBIT growth 1Y-88.9%
EBIT growth 3Y-41.54%
EBIT growth 5Y-11.55%
EBIT Next Year72.2%
EBIT Next 3Y47.19%
EBIT Next 5Y25.08%
FCF growth 1Y-78%
FCF growth 3Y-32.16%
FCF growth 5Y-12.16%
OCF growth 1Y-78.89%
OCF growth 3Y-31.89%
OCF growth 5Y-10.27%